MDK(SH:688079) 智通财经网·2025-12-10 11:19Core Viewpoint - Medike (688079.SH) plans to introduce a strategic investor through its subsidiary Zhejiang Medike Optical Semiconductor Co., Ltd., with an investment of 200 million RMB at a pre-investment valuation of 2.18 billion RMB [1] Group 1: Investment Details - The strategic investor, Zhejiang Fuzhe Shaoxin Integrated Circuit Industry Fund Partnership (Limited Partnership), will acquire an 8.40% stake in the optical semiconductor company after the capital increase [1] - The funds from this capital increase will primarily be used for the main business operations of the optical semiconductor company and other purposes agreed upon by the investor [1] Group 2: Strategic Implications - The introduction of the strategic investor is expected to enhance the financial strength of the optical semiconductor company, better meeting the capital needs for its business development [1] - This capital increase aims to aggregate various advantageous resources to create synergies, further improving the core competitiveness and sustainable development capabilities of the optical semiconductor company [1] - After the completion of the capital increase, Medike will remain the controlling shareholder of the optical semiconductor company, which will continue to be included in Medike's consolidated financial statements [1]